PULSE BIOSCIENCES, INC. — Director's Dealing 2017

Dec 15, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2017-12-13

Reporting Person: Zanganeh Maky (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-13	Common Stock	P	1100	$23.98	Acquired	95574	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	332500	Direct